1. Home
  2. TECH vs TOST Comparison

TECH vs TOST Comparison

Compare TECH & TOST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • TOST
  • Stock Information
  • Founded
  • TECH 1976
  • TOST 2012
  • Country
  • TECH United States
  • TOST United States
  • Employees
  • TECH N/A
  • TOST N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • TOST EDP Services
  • Sector
  • TECH Health Care
  • TOST Technology
  • Exchange
  • TECH Nasdaq
  • TOST Nasdaq
  • Market Cap
  • TECH 12.5B
  • TOST 16.2B
  • IPO Year
  • TECH 1989
  • TOST 2021
  • Fundamental
  • Price
  • TECH $70.15
  • TOST $29.55
  • Analyst Decision
  • TECH Buy
  • TOST Buy
  • Analyst Count
  • TECH 9
  • TOST 20
  • Target Price
  • TECH $80.67
  • TOST $27.50
  • AVG Volume (30 Days)
  • TECH 750.5K
  • TOST 5.0M
  • Earning Date
  • TECH 10-30-2024
  • TOST 11-05-2024
  • Dividend Yield
  • TECH 0.46%
  • TOST N/A
  • EPS Growth
  • TECH N/A
  • TOST N/A
  • EPS
  • TECH 1.05
  • TOST N/A
  • Revenue
  • TECH $1,159,060,000.00
  • TOST $4,386,000,000.00
  • Revenue This Year
  • TECH $6.90
  • TOST $29.18
  • Revenue Next Year
  • TECH $9.69
  • TOST $22.35
  • P/E Ratio
  • TECH $66.81
  • TOST N/A
  • Revenue Growth
  • TECH 1.97
  • TOST 32.19
  • 52 Week Low
  • TECH $51.79
  • TOST $13.77
  • 52 Week High
  • TECH $85.57
  • TOST $29.92
  • Technical
  • Relative Strength Index (RSI)
  • TECH 36.27
  • TOST 65.03
  • Support Level
  • TECH $72.16
  • TOST $27.65
  • Resistance Level
  • TECH $75.17
  • TOST $29.52
  • Average True Range (ATR)
  • TECH 1.94
  • TOST 0.94
  • MACD
  • TECH -0.61
  • TOST -0.01
  • Stochastic Oscillator
  • TECH 2.18
  • TOST 96.88

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About TOST Toast Inc.

Toast is a us-based restaurant technology company that provides point-of-sale, payment processing, and various software services to 120,000 restaurant locations across the United States at the end of June 2024. The firm generates sales from software subscription fees, as a percentage take rate from each financial transaction it processes, from loan origination and servicing fees from its Toast Capital arm, and from hardware installation and professional services. Unlike competitors, Toast intermediates every payment transaction on its platform, processing some $126 billion in gross platform volume in 2023. The firm's product offerings span point-of-sale systems, inventory and payroll management, delivery integration, e-commerce ordering, reservation management, and loyalty programs.

Share on Social Networks: